HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 0.52
Day range
kr 0.46 - kr 0.54
Year range
kr 0.36 - kr 2.21
Market cap
55.92M SEK
Avg Volume
213.85K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.11M | -21.05% |
Operating expense | 14.30M | -3.60% |
Net income | -5.64M | -83.63% |
Net profit margin | -39.98 | -132.58% |
Earnings per share | — | — |
EBITDA | -4.96M | -30.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.78M | -52.91% |
Total assets | 33.84M | -35.32% |
Total liabilities | 30.21M | 9.40% |
Total equity | 3.63M | — |
Shares outstanding | 69.82M | — |
Price to book | 10.40 | — |
Return on assets | -34.46% | — |
Return on capital | -202.72% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.64M | -83.63% |
Cash from operations | -5.52M | 40.54% |
Cash from investing | -29.00K | 96.16% |
Cash from financing | — | — |
Net change in cash | -6.27M | 37.56% |
Free cash flow | -4.38M | 54.01% |
About
Founded
2009
Website
Employees
38
